EverBlu’s Blumenthal accepts five-year ban and ASIC fine

SYDNEY: ormer Creso Pharmaceuticals and EverBlu Capital chair Adam Blumenthal has agreed to ... read more

CarthRX gathers fresh funds via new funding round

MELBOURNE: Privately held medical device company CathRx has ruled off a $4 million ... read more

KPJ aims to finalise Australian aged care business disposal

KUALA LUMPUR: KPJ Healthcare Berhad (“KPJ Healthcare” or the “Group”), Malaysia’s largest private ... read more

ACL set to now pull Healius bid as shake-up barred

SYDNEY: The No.3 player in the pathology market, Australian Clinical Labs, still thinks ... read more